[1]
Giffin Daughtridge et al. 2020. The Time is Now for Disruptive Innovation in Pre-Exposure Prophylaxis Adherence Monitoring. HIV/AIDS Research and Treatment. 7, 1 (Jul. 2020), 5–9. DOI:https://doi.org/10.17140/HARTOJ-7-133.